Turkish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

To Evaluate if the Medication Gabapentin Lessens Vulvar Pain

Sadece kayıtlı kullanıcılar makaleleri çevirebilir
Giriş yapmak kayıt olmak
Bağlantı panoya kaydedilir
DurumSonlandırılmış
Sponsorlar
Colleen Stockdale

Anahtar kelimeler

Öz

The purpose of this research study is to evaluate if the medication gabapentin lessens the vulvar pain some women experience.

Açıklama

There is not a "best" treatment plan for vulvar pain including vulvodynia (chronic vulvar pain) and vulvar vestibulitis syndrome (VVS, chronic vulvar pain localized to the vaginal opening). We propose that vulvodynia is a neuropathic pain (pain that effects the nervous system) as characterized by pain from stimuli that is not usually painful, stimuli that would not usually be painful causing significant pain, and burning pain. Gabapentin has been shown to be effective in treating chronic pain.

Tarih

Son Doğrulandı: 06/30/2017
İlk Gönderilen: 10/17/2006
Tahmini Kayıt Gönderildi: 10/17/2006
İlk Gönderilen: 10/18/2006
Son Güncelleme Gönderildi: 07/27/2017
Son Güncelleme Gönderildi: 07/30/2017
İlk gönderilen sonuçların tarihi: 03/29/2017
QC sonuçlarının ilk gönderildiği tarih: 07/27/2017
İlk yayınlanan sonuçların tarihi: 07/30/2017
Fiili Çalışma Başlangıç Tarihi: 12/31/2006
Tahmini Birincil Tamamlanma Tarihi: 02/29/2008
Tahmini Çalışma Tamamlanma Tarihi: 02/29/2008

Durum veya hastalık

Vulvar Pain Symptoms
Vulvodynia (Chronic Vulvar Pain)

Müdahale / tedavi

Drug: Gabapentin

Drug: Placebo oral capsule

Evre

-

Kol Grupları

KolMüdahale / tedavi
Active Comparator: Gabapentin
Gabapentin (Neurontin) titration and dosing for total of 8 weeks (Cross over)
Drug: Gabapentin
300 mg. capsules Dosage schedule for weeks 1 and 2 and weeks 12 and 13: day 1 you will take 1 capsule for the day day 2 you will take 1 capsule 2 times for that day days 3-6 you will take 1 capsule 3 times for those days days 7-9 you will take 1 capsule in am and 1 capsule at noon, 2 capsules at bedtime each day days 10-12 you will take 1 capsule in am and 2 capsules at noon and 2 capsules at bedtime each day days 13-14 you will take 2 capsules 3 times each day continue on 2 capsules 3 times each day for 6 weeks after maximum dose of 1800 mg is reached after weeks 2 and 13. at completion of study treatment you will titrate off study drug over a weeks time.
Placebo Comparator: Placebo oral capsule
Placebo titration and dosing for total of 8 weeks (Cross over)
Drug: Placebo oral capsule
Placebo capsules Dosage schedule for weeks 1 and 2 and weeks 12 and 13: day 1 you will take 1 capsule for the day day 2 you will take 1 capsule 2 times for that day days 3-6 you will take 1 capsule 3 times for those days days 7-9 you will take 1 capsule in am and 1 capsule at noon, 2 capsules at bedtime each day days 10-12 you will take 1 capsule in am and 2 capsules at noon and 2 capsules at bedtime each day days 13-14 you will take 2 capsules 3 times each day continue on 2 capsules 3 times each day for 6 weeks after maximum dose of 1800 mg is reached after weeks 2 and 13. at completion of study treatment you will titrate off study drug over a weeks time.

Uygunluk kriterleri

Çalışmaya Uygun Yaşlar 18 Years İçin 18 Years
Çalışmaya Uygun CinsiyetlerFemale
Sağlıklı Gönüllüleri Kabul EdiyorEvet
Kriterler

Inclusion Criteria:

- All women, ages 18 years and older with the diagnosis of vulvodynia or VVS (by Friedrich's criteria), who present to the University of Iowa Vulvar Vaginal Disease Clinic.

Exclusion Criteria:

- Vulvar Vaginal Disease clinic patients who are pregnant, less than 3 months postpartum, breast-feeding, non-English speaking, or have contraindication to use of gabapentin due to allergy or renal disease (serum creatinine level greater than 1.4).

Sonuç

Birincil Sonuç Ölçütleri

1. Change From Baseline in Vulvar Pain [19 weeks]

change in vulvar pain following gabapentin compared to placebo - will evaluate the efficacy of gabapentin to decrease vulvar pain compared to placebo. end of 1st treatment (after 8 weeks) and end of 2nd treatment (after 19 weeks). Pain was assessed using ordinal scale (0-10): 0 = no pain, 10 = most severe pain.

Facebook sayfamıza katılın

Bilim tarafından desteklenen en eksiksiz şifalı otlar veritabanı

  • 55 dilde çalışır
  • Bilim destekli bitkisel kürler
  • Görüntüye göre bitki tanıma
  • Etkileşimli GPS haritası - bölgedeki bitkileri etiketleyin (yakında)
  • Aramanızla ilgili bilimsel yayınları okuyun
  • Şifalı bitkileri etkilerine göre arayın
  • İlgi alanlarınızı düzenleyin ve haber araştırmaları, klinik denemeler ve patentlerle güncel kalın

Bir belirti veya hastalık yazın ve yardımcı olabilecek bitkiler hakkında bilgi edinin, bir bitki yazın ve karşı kullanıldığı hastalıkları ve semptomları görün.
* Tüm bilgiler yayınlanmış bilimsel araştırmalara dayanmaktadır

Google Play badgeApp Store badge